OMNICARE INC's ticker is OCR and the CUSIP is 681904108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $17,807,000 | +8.2% | 188,939 | -11.5% | 1.88% | +3.2% |
Q1 2015 | $16,452,000 | -0.9% | 213,497 | -6.2% | 1.82% | +4.7% |
Q4 2014 | $16,598,000 | +14.3% | 227,587 | -2.4% | 1.74% | +6.7% |
Q3 2014 | $14,517,000 | -6.5% | 233,168 | -0.0% | 1.63% | -21.5% |
Q2 2014 | $15,525,000 | +11.8% | 233,215 | +0.2% | 2.07% | +10.6% |
Q1 2014 | $13,891,000 | -0.5% | 232,804 | +0.6% | 1.87% | -3.8% |
Q4 2013 | $13,964,000 | +13.8% | 231,340 | +4.6% | 1.95% | -19.3% |
Q3 2013 | $12,273,000 | – | 221,146 | – | 2.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IRIDIAN ASSET MANAGEMENT LLC/CT | 5,049,268 | $368,243,000 | 3.42% |
HealthCor Management, L.P. | 675,000 | $49,228,000 | 2.74% |
Somerset Group LLC | 34,975 | $2,551,000 | 2.27% |
SANDLER CAPITAL MANAGEMENT | 497,500 | $36,283,000 | 1.91% |
Clarkston Capital Partners, LLC | 170,650 | $12,446,000 | 1.88% |
EXANE DERIVATIVES | 180,712 | $13,178,888,000 | 1.83% |
Atika Capital Management LLC | 33,000 | $2,407,000 | 1.76% |
COLONY GROUP LLC | 227,587 | $16,598,000 | 1.74% |
COLRAIN CAPITAL LLC | 257,000 | $18,743,000 | 1.45% |
SAMLYN CAPITAL, LLC | 1,056,021 | $77,015,000 | 1.34% |